Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling.

Pan G, Ni J, Yu G, Wei YF, Dixit VM.

FEBS Lett. 1998 Mar 6;424(1-2):41-5.

2.

Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Schneider P, Olson D, Tardivel A, Browning B, Lugovskoy A, Gong D, Dobles M, Hertig S, Hofmann K, Van Vlijmen H, Hsu YM, Burkly LC, Tschopp J, Zheng TS.

J Biol Chem. 2003 Feb 14;278(7):5444-54. Epub 2002 Dec 3.

4.

Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B.

Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD, Ashkenazi A.

Curr Biol. 1996 Dec 1;6(12):1669-76.

5.

TRAIL-induced signalling and apoptosis.

MacFarlane M.

Toxicol Lett. 2003 Apr 4;139(2-3):89-97. Review.

PMID:
12628743
6.
7.

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL.

Screaton GR, Mongkolsapaya J, Xu XN, Cowper AE, McMichael AJ, Bell JI.

Curr Biol. 1997 Sep 1;7(9):693-6.

8.

Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL.

Mongkolsapaya J, Cowper AE, Xu XN, Morris G, McMichael AJ, Bell JI, Screaton GR.

J Immunol. 1998 Jan 1;160(1):3-6.

9.

Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.

Jaganathan J, Petit JH, Lazio BE, Singh SK, Chin LS.

Neurosurg Focus. 2002 Sep 15;13(3):ecp1.

PMID:
15844877
11.

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.

Degli-Esposti MA, Dougall WC, Smolak PJ, Waugh JY, Smith CA, Goodwin RG.

Immunity. 1997 Dec;7(6):813-20.

12.

A novel receptor for Apo2L/TRAIL contains a truncated death domain.

Marsters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D, Yuan J, Gurney A, Goddard AD, Godowski P, Ashkenazi A.

Curr Biol. 1997 Dec 1;7(12):1003-6.

13.

Identification of tumor necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL) and its receptors in adult rat ventral prostate.

Vindrieux D, Devonec M, Benahmed M, Grataroli R.

Mol Cell Endocrinol. 2002 Dec 30;198(1-2):115-21.

PMID:
12573821
15.
16.

TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.

Vindrieux D, Réveiller M, Florin A, Blanchard C, Ruffion A, Devonec M, Benahmed M, Grataroli R.

J Cell Physiol. 2006 Mar;206(3):709-17.

PMID:
16245307
17.
18.

Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells.

Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ.

J Immunol. 1998 Sep 15;161(6):2833-40.

19.

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.

Suliman A, Lam A, Datta R, Srivastava RK.

Oncogene. 2001 Apr 19;20(17):2122-33.

20.

Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.

Griffith TS, Fialkov JM, Scott DL, Azuhata T, Williams RD, Wall NR, Altieri DC, Sandler AD.

Cancer Res. 2002 Jun 1;62(11):3093-9.

Supplemental Content

Support Center